Source:http://linkedlifedata.com/resource/pubmed/id/12552995
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6B
|
pubmed:dateCreated |
2003-1-29
|
pubmed:abstractText |
CYFRA 21-1 is a tumor marker that is useful for detecting squamous cell carcinoma (SCC) of the lung. Tissue polypeptide specific antigen (TPS) is a tumor marker that indicates tumor proliferative rate rather than tumor burden. Our aim in this study was to compare the clinical value of CYFRA 21-1 and TPS in the detection of nasopharyngeal carcinoma (NPC). Serum levels of CYFRA 21-1 and TPS were measured in 60 patients with untreated NPC (including 36 differentiated SCC and 24 undifferentiated carcinomas) for comparison with each other. The cut-off values of CYFRA 21-1 and TPS, determined at the 95th percentile of the 43 healthy controls, were 2.50 ng/ml and 115.2 U/l, respectively. The results revealed that the mean serum values of CYFRA 21-1 (6.20 +/- 5.21 ng/ml) and TPS (153.9 +/- 17.3 U/l) in all 60 NPC patients were significantly higher than that in the 43 healthy controls (CYFRA 21-1 = 1.32 + 0.50 ng/ml, TPS = 85.0 +/- 16.0 U/l) (p value < 0.05). In addition, the detecting sensitivities of CYFRA 21-1 (60.0%) and TPS (58.3%) for all 60 NPC were not significantly different (p value > 0.05). In conclusion, our results suggest that both CYFRA 21-1 and TPS are potential tumor markers for the detection of NPC.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Keratin-19,
http://linkedlifedata.com/resource/pubmed/chemical/Keratins,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/antigen CYFRA21.1,
http://linkedlifedata.com/resource/pubmed/chemical/tissue polypeptide specific antigen
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3793-6
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:12552995-Adult,
pubmed-meshheading:12552995-Aged,
pubmed-meshheading:12552995-Antigens, Neoplasm,
pubmed-meshheading:12552995-Carcinoma,
pubmed-meshheading:12552995-Carcinoma, Squamous Cell,
pubmed-meshheading:12552995-Female,
pubmed-meshheading:12552995-Humans,
pubmed-meshheading:12552995-Keratin-19,
pubmed-meshheading:12552995-Keratins,
pubmed-meshheading:12552995-Male,
pubmed-meshheading:12552995-Middle Aged,
pubmed-meshheading:12552995-Nasopharyngeal Neoplasms,
pubmed-meshheading:12552995-Neoplasm Staging,
pubmed-meshheading:12552995-Peptides,
pubmed-meshheading:12552995-Sensitivity and Specificity,
pubmed-meshheading:12552995-Tumor Markers, Biological
|
pubmed:articleTitle |
Comparison of CYFRA 21-1 and tissue polypeptide specific antigen (TPS) for detecting nasopharyngeal carcinoma.
|
pubmed:affiliation |
Department of Otolaryngology, China Medical College Hospital, No. 2, Yuh-Der Road, Taichung 404, Taiwan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|